Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
Bucladesine sodium
Cat. No.:
0225LY-1038
Appearance:
Solid
Purity:
≥99%
Identity:
Confirmed by NMR, and HPLC.
Size:
Add to basket
Product Overview
Description:
Bucladesine sodium is a cell-permeable cAMP analog that activates PKA and inhibits PDE, exhibiting notable anti-inflammatory activity.
Synonym:
dbcAMP; Dibutyryl-cAMP sodium salt; Dibutyryl-cAMP; DC2797; Sodium dibutyryl cAMP; Bucladesine; Bucladesine sodium salt; 16980-89-5; Bucladesine; Bucladesine sodium salt; Bucladesine (sodium); Dibutyryl-cAMP, sodium salt; Dibutyryl-cAMP sodium salt; Bucladesine (sodium salt); N-6,O-2'-Dibutyryladenosine cyclic 3',5'-monophosphate sodium salt; N6,2'-O-Dibutyryladenosine 3',5'-cyclic monophosphate sodium salt; Sodium (4aR,6R,7R,7aR)-6-(6-butyramido-9H-purin-9-yl)-7-(butyryloxy)tetrahydro-4H-furo[3,2-d][1,3,2]dioxaphosphinin-2-olate 2-oxide; sodium;[(4aR,6R,7R,7aR)-6-[6-(butanoylamino)purin-9-yl]-2-oxido-2-oxo-4a,6,7,7a-tetrahydro-4H-furo[3,2-d][1,3,2]dioxaphosphinin-7-yl] butanoate
CAS No.:
16980-89-5
Compound CID:
23663967
Formula:
C18H23N5NaO8P
Formula Weight:
491.37
Specification
Stability:
3 years in powder form.
Storage:
Storage at -20°C.
Applications:
Bucladesine sodium can be used in cellular signaling studies to investigate the effects of increased intracellular cyclic AMP levels.
Library Information
Target:
PKA; PDE
Receptor:
PKA; PDE
Pathways:
Metabolism; Tyrosine kinase/adaptors
Plate Number:
AOCL-14
Plate Location:
c11
Empty Location:
a1-h1; a12-h12
Container:
96-well plate
Formulation:
10mM DMSO
DMSO Max Solubility:
144 mg/mL; 293.06 mM
Water Max Solubility:
200 mg/mL; 407.03 mM
ALogP:
1.028
HBA_Count:
10
HBD_Count:
1
Rotatable Bond:
9
